Allergan to Buy MAP Pharmaceuticals for $958M

Jan. 22 (Bloomberg) -- Allergan agreed to pay $25 per share for MAP Pharmaceuticals in what the companies called a “definitive merger agreement.” Matt Miller reports on Bloomberg Television's "Bloomberg Rewind." (Source: Bloomberg)

New York Times CEO on Digital Subscribers, Social Media
35:42 - Mark Thompson, New York Times Co.'s chief executive officer, discusses the company's digital subscriber growth and social media partnerships with Bloomberg's David Gura at the JPMorgan Media and Telecom Conference in Boston on "Bloomberg Markets." (Source: Bloomberg)
  • Kahneman Not Sure Trump Running Country Like a Business
  • Kirkland & Ellis Partner Sees M&A Market Optimism
  • How CLOs Are Adapting to a New Regulatory Environment